Pablo Corral: “The lower, The better” Applies to The Brain Too
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, posted on LinkedIn:
”Lower LDL-C, Lower Risk – Safely
New analysis from FOURIER & FOURIER-OLE (Monguillon et al., Circulation 2025):
In patients with prior ischemic stroke, achieving LDL-C <40 mg/dL led to a continuous reduction in MACE and recurrent stroke, without any increase in hemorrhagic stroke.
- 5,291 stroke patients
- Follow-up up to 7 years
- Stepwise reduction in cardiovascular and ischemic events with lower LDL-C
- Hemorrhagic strokes: rare and unrelated to LDL-C
Conclusion: Very low LDL-C levels (<40 mg/dL) are both effective and safe for secondary prevention after stroke – confirming that “the lower, the better” also applies to the brain.”
Read the full article here.
Title: Efficacy and Safety of Very Low Achieved LDL-Cholesterol in Patients with Prior Ischemic Stroke
Authors: Victorien Monguillon, Peter Kelly, Michelle L. O’Donoghue, Jeong-Gun Park, Erin A. Bohula, Jeffrey L. Saver, Dan Atar, Anthony C. Keech, Peter S. Sever, Huei Wang, Gabriel Paiva da Silva Lima, Marc S. Sabatine, Robert P. Giugliano
Stay updated with Hemostasis Today.
-
Jul 5, 2026, 04:54Saneha Anjum Shaik: What Every Clinician Should Know Before Ordering Blood Tests
-
Jul 5, 2026, 04:37Mathis Richter: How The Bone Marrow Responds To Myocardial Infarction Predicts Clinical Outcome
-
Jul 5, 2026, 02:45Marie Luise Hütter-Krönke: Can a Short Course of BCMA-Targeted Therapy Induce Long-Term Remission in Refractory Autoimmune Disease?
-
Jul 5, 2026, 02:24Shreya Agarwa: Transforming Care For Adolescents With Heavy Menstrual Bleeding
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins